Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
US FDA approves Regeneron’s rare bone disorder drug
45+ min ago (162+ words) Aug 19 – The U.S. FDA on Wednesday approved Regeneron’s experimental drug for a rare genetic disorder after it significantly reduced abnormal bone formation in certain soft tissues. The New York-based Regeneron’s shares rose 4%. The drug, garetosmab, branded as Pasatru, was approved…...
Slipping Through the Cracks: How Medicine Has Gotten Better??? and Worse
10+ min ago (1747+ words) There may be no worse place to be than in a body that’s failing when the doctors can’t tell you what’s wrong. Looking back at everything now, I realize that almost all of my assumptions about modern medicine were wrong....
Novel 1-time treatment cuts seizures by over 95% in Dravet mice
1+ day, 45+ min ago (987+ words) Gene-targeting therapy also shown to boost animal's survival Written by Michela Luciano, PhD | Aug. 18, 2026 A one-time treatment designed to boost the activity of a gene deficient in most people with Dravet syndrome significantly reduced seizures — both fever-triggered and spontaneous — in…...
Strength training during pregnancy may help reduce diabetes risk
5+ hour, 28+ min ago (18+ words) Yahoo Life UK Your privacy is important to us...
Another measles case confirmed in metro Atlanta
11+ min ago (136+ words) The Georgia Department of Public Health has confirmed another case of measles in the metro Atlanta area. Health officials say the person was unvaccinated and had no known recent travel history. Measles is highly contagious and can spread through the…...
Video Personalized mRNA-based cancer vaccine shows promise
22+ min ago (398+ words) ABC News - Breaking News, Latest News and Videos Personalized mRNA-based cancer vaccine shows promise Drugmakers Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large late-stage trial involving high-risk melanoma patients. Dow Jones Industrial Average…...
Personalized cancer vaccine shows positive late-stage trial results
1+ hour, 7+ min ago (18+ words) KPAX News Personalized cancer vaccine shows positive late-stage trial results...
Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder
27+ min ago (655+ words) After more than 10 years in development, Regeneron secured a landmark approval for its monoclonal antibody garetosmab, now commercially known as Pasatru. The drug has become the second cleared by the FDA to treat fibrodysplasia ossificans progressiva (FOP) and the first…...
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
5+ hour, 2+ min ago (263+ words) Moderna and Merck said their new mRNA vaccine showed signs of preventing melanoma from spreading or returning and could eventually be used to treat a wide spectrum of cancers. Pharmaceutical giants Moderna and Merck said Wednesday that an experimental vaccine…...
Watch Dr. Tomia Austin explain the danger of sickle cell trait
37+ min ago (82+ words) Rolling Out Watch Dr. Tomia Austin explain the danger of sickle cell trait Dr. Tomia Austin, public health expert and Executive Director of the As One Foundation, joins Rolling Out to break down sickle cell trait, the genetic risks it…...